FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

8 results

cefepime
(Cefepime)
WG Critical Care, LLC
Usage: Cefepime is indicated for treating moderate to severe pneumonia, febrile neutropenia, uncomplicated and complicated urinary tract infections, uncomplicated skin infections, and complicated intra-abdominal infections (with metronidazole). It should be used to target infections caused by susceptible bacteria to prevent drug resistance.
cefepime
(cefepime)
Baxter Healthcare Corporation
Usage: Cefepime Injection is indicated for treating moderate to severe pneumonia, febrile neutropenia, uncomplicated and complicated urinary tract infections, uncomplicated skin infections, and complicated intra-abdominal infections. It should be used to combat infections caused by specific susceptible bacteria to prevent drug resistance.
cefepime
(Cefepime)
Apotex Corp.
Usage: Cefepime for Injection is indicated for treating moderate to severe pneumonia, febrile neutropenia, uncomplicated and complicated urinary tract infections, uncomplicated skin infections, and complicated intra-abdominal infections (with metronidazole). It should be used when infections are proven or suspected to be caused by susceptible bacteria.
ciprofloxacin
(ciprofloxacin)
Sagent Pharmaceuticals
Usage: Ciprofloxacin Injection is indicated for adult patients to treat various infections, including skin and skin structure, bone and joint, complicated intra-abdominal, nosocomial pneumonia, febrile neutropenia, inhalational anthrax, plague, chronic bacterial prostatitis, lower respiratory tract, and urinary tract infections, alongside pediatric applications for certain conditions.
ciprofloxacin in dextrose
(ciprofloxacin)
Hospira, Inc.
Usage: Ciprofloxacin Injection is indicated for treating various infections in adults, including skin, bone and joint, complicated intra-abdominal, nosocomial pneumonia, febrile neutropenia, inhalational anthrax (post-exposure), plague, chronic bacterial prostatitis, lower respiratory tract infections, complicated urinary tract infections, and acute sinusitis.
neulasta
(pegfilgrastim)
Amgen Inc
Usage: Neulasta is indicated to reduce the incidence of febrile neutropenia in cancer patients receiving myelosuppressive chemotherapy, and to enhance survival in patients exposed to myelosuppressive doses of radiation. It is not indicated for mobilizing peripheral blood progenitor cells for stem cell transplantation.
nyvepria
(pegfilgrastim-apgf)
Pfizer Laboratories Div Pfizer Inc
Usage: NYVEPRIA is indicated to reduce the risk of infection, specifically febrile neutropenia, in patients with non-myeloid malignancies undergoing myelosuppressive anti-cancer therapy. It is not intended for mobilizing peripheral blood progenitor cells for stem cell transplantation.
rolvedon
(eflapegrastim-xnst)
Spectrum Pharmaceuticals, Inc.
Usage: Rolvedon is indicated to reduce the incidence of febrile neutropenia in adult patients with non-myeloid malignancies undergoing myelosuppressive chemotherapy. It is not intended for mobilizing peripheral blood progenitor cells for stem cell transplantation.

Medications for Febrile Neutropenia

cefepime

cefepime

cefepime

ciprofloxacin

ciprofloxacin in dextrose

neulasta

nyvepria

rolvedon